Literature DB >> 3263311

Short-term lymphokine stimulation of human peripheral blood mononuclear cells generates cytolytic activity against endothelial cells: involvement of natural killer cells.

A M Miltenburg1, M E Meijer-Paape, M R Daha, L C Paul.   

Abstract

UNLABELLED: We previously reported that incubation of human peripheral blood mononuclear cells (PBMC) for 5 days with T-cell growth factor (TCGF) resulted in lymphokine-activated killer activity against endothelial cells (EC). In this paper we report on the effects of short-term incubation of PBMC with lymphokines. We show that incubation of PBMC with lymphokines during an 18-hr period is sufficient to generate a strong cytolytic response against EC. The cytolytic capacity of the effector cells was directly dependent on the dose of lymphokine added during the induction phase. When PBMC were separated into adherent and non-adherent cells, the non-adherent fraction could be induced to lytic activity against EC, whereas the adherent cells could not. When PBMC were separated, using 2-amino-ethylisothiouronium bromide hydrobromide-treated sheep red blood cells (AET-SRBC), into T- and non-T-cell fractions, the latter fraction could be induced to lyse EC. TCGF-induced cell-mediated EC lysis could not be inhibited using anti-T3 nor anti-LFA-1 antibodies. Lysis of EC by TCGF-stimulated effector cells was strongly inhibited by the addition of unlabelled K562 target cells, whereas cold OKT3 hybridoma cells did not exert such an effect. IN
CONCLUSION: the kinetics of the induction of lytic activity against EC, as well as the cell separation experiments, suggest that short-term-activated NK cells may lyse EC. This hypothesis was confirmed using monoclonal antibody and cold target cell analysis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3263311      PMCID: PMC1385027     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  24 in total

1.  Identification of the C3bi receptor of human monocytes and macrophages by using monoclonal antibodies.

Authors:  S D Wright; P E Rao; W C Van Voorhis; L S Craigmyle; K Iida; M A Talle; E F Westberg; G Goldstein; S C Silverstein
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

2.  Increase of natural killer cells in rejecting kidney grafts.

Authors:  B Weber; M Welte; C Hammer; J Stadler; C Koller; C Caspo; W Land; G Hillebrand; M Castro
Journal:  Transplant Proc       Date:  1984-10       Impact factor: 1.066

3.  Are "natural killer" cells involved in allograft rejection?

Authors:  A Nemlander; E Saksela; P Häyry
Journal:  Eur J Immunol       Date:  1983-04       Impact factor: 5.532

4.  T cell enrichment and depletion of human peripheral blood mononuclear cell preparations. Unexpected findings in the study of the functional activities of the separated populations.

Authors:  R M Falkoff; M Peters; A S Fauci
Journal:  J Immunol Methods       Date:  1982       Impact factor: 2.303

5.  Recruitment of unsensitized circulating lymphocytes to sites of allogeneic cellular interactions.

Authors:  D W Hanto; U T Hopt; R Hoffman; R L Simmons
Journal:  Transplantation       Date:  1982-05       Impact factor: 4.939

6.  The immunologic and ultrastructural characterization of the cellular infiltrate in acute cardiac allograft rejection: prevalence of cells with the natural killer (NK) phenotype.

Authors:  C C Marboe; D M Knowles; L Chess; K Reemtsma; J J Fenoglio
Journal:  Clin Immunol Immunopathol       Date:  1983-04

7.  Fc and C3 receptors induced by herpes simplex virus on cultured human endothelial cells.

Authors:  D B Cines; A P Lyss; M Bina; R Corkey; N A Kefalides; H M Friedman
Journal:  J Clin Invest       Date:  1982-01       Impact factor: 14.808

8.  Modulation of human natural killer cell activity by recombinant human interleukin 2.

Authors:  A R Shaw; R C Bleackley; J P Merryweather; P J Barr
Journal:  Cell Immunol       Date:  1985-02       Impact factor: 4.868

9.  Augmentation of human natural cell-mediated cytotoxicity by recombinant human interleukin 2.

Authors:  L P Svedersky; H M Shepard; S A Spencer; M R Shalaby; M A Palladino
Journal:  J Immunol       Date:  1984-08       Impact factor: 5.422

10.  Response of resting human peripheral blood natural killer cells to interleukin 2.

Authors:  G Trinchieri; M Matsumoto-Kobayashi; S C Clark; J Seehra; L London; B Perussia
Journal:  J Exp Med       Date:  1984-10-01       Impact factor: 14.307

View more
  1 in total

1.  Activated, cytotoxic lymphocytes in systemic vasculitis.

Authors:  A D Blann; D G Scott
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.